What is the appropriate Augmentin (amoxicillin/clavulanate) dosage for a 101‑lb (≈46 kg) male?

Augmentin Dosing for a 101 lb (46 kg) Male

For a 101 lb (46 kg) male, the appropriate Augmentin dose depends entirely on the specific infection being treated, but standard adult dosing is typically 500 mg/125 mg three times daily or 875 mg/125 mg twice daily for most common infections.

Key Dosing Considerations by Indication

For Respiratory Tract Infections (Community-Acquired Pneumonia, Sinusitis)

• Standard adult dosing: 875 mg/125 mg twice daily or 500 mg/125 mg three times daily 1
• At 46 kg, this patient exceeds the pediatric weight threshold (typically <40 kg) where weight-based dosing applies 1
• For β-lactamase producing Haemophilus influenzae in pneumonia, guidelines recommend amoxicillin-clavulanate at 45 mg/kg/day (amoxicillin component) in 3 doses or 90 mg/kg/day in 2 doses for pediatric patients 2
• However, since this patient weighs 46 kg, standard adult tablets (875/125 mg twice daily) are more practical and appropriate than calculating pediatric suspension doses 1

For Skin and Soft Tissue Infections

• Standard dosing: 875 mg/125 mg twice daily 2
• For impetigo or uncomplicated SSTI: 875/125 mg twice daily is appropriate 2
• Duration typically 7-10 days depending on clinical response 2

For Group A Streptococcal Pharyngitis (Chronic Carriers)

• Dosing: 40 mg/kg/day of amoxicillin component in three doses (maximum 2,000 mg/day) for 10 days 2
• For a 46 kg patient: approximately 1,840 mg/day amoxicillin component
• Practical approach: 875/125 mg twice daily (1,750 mg amoxicillin/day) is the closest standard formulation 2

For Complicated Intra-Abdominal Infections (Pediatric Context)

• Guidelines do not provide specific adult dosing for amoxicillin-clavulanate in this setting 2
• This combination is not a preferred agent for complicated intra-abdominal infections in adults 2

Critical Dosing Principles

Weight-Based vs. Standard Adult Dosing

• The FDA label specifies that AUGMENTIN ES-600 (high-dose pediatric formulation) is for patients weighing <40 kg 1
• At 46 kg (101 lbs), this patient should receive standard adult tablet formulations rather than pediatric suspensions 1
• Adult dosing does not require weight-based calculation for patients ≥40 kg 1

Formulation Selection

• Standard adult tablets: 500/125 mg or 875/125 mg 1
• The 875/125 mg twice-daily formulation provides better compliance than 500/125 mg three times daily 3
• Do not substitute different suspension formulations - they contain different ratios of clavulanate and are not interchangeable 1

Administration Timing

• Take at the start of meals to minimize gastrointestinal intolerance and enhance clavulanate absorption 1
• This is particularly important for tolerability, as diarrhea is the most common adverse effect 1

Common Pitfalls to Avoid

Storage and Stability

• Reconstituted suspensions must be refrigerated and are stable for only 10 days 1
• Exposure to high temperatures (e.g., leaving in a hot car) degrades the antibiotic and renders it ineffective 4
• Tablets are more stable than suspensions for patients who may have storage challenges 4

Dosing Errors

• Do not use pediatric weight-based dosing formulas for patients ≥40 kg - use standard adult tablets instead 1
• The maximum adult dose is 2,000 mg/day of the amoxicillin component for most indications 2
• For severe infections or resistant organisms, higher doses may be considered, but standard dosing is appropriate for most community-acquired infections 2, 5

Resistance Considerations

• Amoxicillin-clavulanate is classified as an "Access" antibiotic by WHO AWaRe criteria, indicating it should be first-line for appropriate infections 6
• Avoid empirical use for infections likely caused by ESBL-producing organisms (e.g., healthcare-associated UTIs) 7
• The combination is effective against β-lactamase-producing H. influenzae and M. catarrhalis but not against MRSA 2

Practical Recommendation

For this 101 lb (46 kg) male, prescribe Augmentin 875 mg/125 mg tablets, one tablet twice daily with meals, for 7-10 days depending on the specific infection 2, 1. This provides adequate dosing for most common community-acquired infections while optimizing compliance and tolerability. If treating a specific resistant pathogen or severe infection, consult organism-specific guidelines for potential dose adjustment 2, 5.